The role of the apoptosome in the activation of procaspase-9;Rola apoptosomu w aktywacji prokaspazy 9

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 67, Issue , 2013, Pages 54-64

  Marek, Łukasz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Apaf 1; Apoptosis; Apoptosome; Caspases; Mitochondrion

Indexed keywords

APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 9; CYTOCHROME C; LIGAND;

APOPTOSIS; ENZYME ACTIVATION; HUMAN; HYDROLYSIS; METABOLISM; MITOCHONDRION; NEOPLASM; PHYSIOLOGY; REVIEW;

APOPTOSIS; APOPTOSOMES; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CASPASE 9; CYTOCHROMES C; ENZYME ACTIVATION; HUMANS; HYDROLYSIS; LIGANDS; MITOCHONDRIA; NEOPLASMS;

MLCS; MLOWN;

EID: 84878637797     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1032333     Document Type: Article

References (82)

1. Acehan D., Jiang X., Morgan D. G., Heuser J. E., Wang X., Akey C. W.: Tree-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol. Cell., 2002;9:423-432
2. Adams J. M., Cory S.: Apoptosomes: engines for caspase activation. Curr. Opin. Cell Biol., 2002;14:715-720
3. Adrain C., Brumatti G., Martin S. J.: Apoptosomes: protease activation platforms to die from. Trends Biochem. Sci., 2006;31:243-247
4. Ameisen J. C.: On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Difer., 2002;9:367-393
5. Bao Q., Lu W., Rabinowitz J. D., Shi Y.: Calcium blocks formation of apoptosome by preventing nucleotide exchange in Apaf-1. Mol. Cell, 2007;25:181-192
6. Bao Q., Riedl S. J., Shi Y.: Structure of Apaf-1 in the auto-inhibited form: a critical role for ADP. Cell Cycle 2005;4:1001-1003
7. Bao Q., Shi Y.: Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ., 2007;14:56-65
8. Benedict M. A., Hu Y., Inohara N., Núñez G.: Expression and functional analysis of Apaf-1 isoforms. Extra Wd-40 repeat is required for cytochrome c binding and regulated activation of procaspase-9. J. Biol. Chem., 2000;275:8461-8468
9. Boatright K. M., Salvesen G. S.: Mechanisms of caspase activation. Curr. Opin. Cell Biol., 2003;15:725-731
10. Bratton S. B., Lewis J., Butterworth M., Duckett C., Cohen G. M.: XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis. Cell Death Differ., 2002;9:881-892
11. Cain K.: Chemical-induced apoptosis: formation of the Apaf-1 apoptosome. Drug Metab. Rev., 2003;35:337-363
12. Cain K., Bratton S. B., Cohen G. M.: The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie, 2002;84:203-214
13. +inhibit cytochrome c - dependent formation of the apoptosome. J. Biol. Chem., 2001;276:41985-41990
14. Campioni M., Santini D., Tonini G., Murace R., Dragonetti E., Spugnini E. P., Baldi A.: Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance. Exp. Dermatol., 2005;14:811-818
15. Chandra D., Bratton S. B., Person M. D., Tian Y., Martin A. G., Ayres M., Fearnhead H. O., Gandhi V., Tang D. G.: Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome c and inhibiting apoptosome. Cell, 2006;125:1333-1346
16. Chao Y., Shiozaki E. N., Srinivasula S. M., Rigotti D. J., Fairman R., Shi Y.: Engineering a dimeric caspase-9: a reevaluation of the induced proximity model for caspase activation. PLoS Biol., 2005;3:e183
17. Czerski L., Nunez G.: Apoptosome formation and caspase activation: is it different in the heart? J. Mol. Cell Cardiol., 2004;37:643-652
18. D'Amelio M., Tino E., Cecconi F.: The apoptosome: emerging insights and new potential targets for drug design. Pharm. Res., 2008;25:740-751
19. Du C., Fang M., Li Y., Li L., Wang X.: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 2000;102:33-42
20. Fadeel B., Ottosson A., Pervaiz S.: Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance. Cell Death Differ., 2008;15:443-452
21. Grzybowska-Izydorczyk O., Smolewski P.: Rola białek z rodziny inhibitora apoptozy (IAP) w chorobach rozrostowych układu krwiotwórczego. Postȩpy Hig. Med. Dośw., 2008;62:55-63
22. Hajra K. M., Liu J. R.: Apoptosome dysfunction in human cancer. Apoptosis, 2004;9:691-704
23. Hill M. M., Adrain C., Duriez P. J., Creagh E. M., Martin S. J.: Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J., 2004;23:2134-2145
24. Hill M. M., Adrain C., Martin S. J.: Portrait of a killer: the mitochondrial apoptosome emerges from the shadows. Mol. Interv., 2003;3:19-26
25. Horvitz H. R.: Worms, life, and death (Nobel Lecture). Chembiochem, 2003;4:697-711
26. Jia L., Srinivasula S. M., Liu F. T., Newland A. C., Fernandes-Alnemri T., Alnemri E. S., Kelsey S. M.: Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood, 2001;98:414-421
27. Jiang X., Kim H. E., Shu H., Zhao Y., Zhang H., Kofron J., Donnelly. J, Burns D., Ng S. C., Rosenberg S., Wang X.: Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science, 2003;299:223-226
28. Jiang X., Wang X.: Cytochrome C-mediated apoptosis. Annu. Rev. Biochem., 2004;73:87-106
29. Johnson C. E., Huang Y. Y., Parrish A. B., Smith M. I., Vaughn A. E., Zhang Q., Wright K. M., Van Dyke T., Wechsler-Reya R. J., Kornbluth S., Deshmukh M.: Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues. Proc. Natl. Acad. Sci. USA, 2007;104:20820-20825
30. Kamarajan P., Sun N. K., Sun C. L., Chao C. C.: Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line. FEBS Lett., 2001;505:206-212
31. Kazmierczuk A., Kiliańska Z. M.: Plejotropowa aktywnoś ć białek szoku cieplnego. Postȩpy Hig. Med. Dośw., 2009;63:502-521
32. Kazmierczuk A., Kiliańska Z. M.: Rola białek szoku cieplnego w apoptozie komórek. Postȩpy Hig. Med. Dośw., 2010;64:273-283
33. Kiliańska Z. M., Miśkiewicz A.: Kaspazy krȩgowców; ich rola w przebiegu apoptozy. Postȩpy Biol. Kom., 2003;30:129-152
34. Kim H. E., Du F., Fang M., Wang X.: Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc. Natl. Acad. Sci. USA, 2005;102:17545-17550
35. Labȩdzka K., Grzanka A., Izdebska M.: Mitochondrium a śmierć komórki. Postȩpy Hig. Med. Dośw., 2006;60:439-446
36. Lademann U., Cain K., Gyrd-Hansen M., Brown D., Peters D., Jäättelä M.: Diarlyurea compounds inhibit caspase activation by preventing the formation of ∼700 kDa apoptosome complex. Mol. Cell Biol., 2003;23:7829-7837
37. Ledgerwood E. C., Morison I. M.: Targeting the apoptosome for cancer therapy. Clin. Cancer Res., 2009;15:420-424
38. Liu J. R., Opipari A. W., Tan L., Jiang Y., Zhang Y., Tang H., Nunez G.: Dysfunctional apoptosome activation in ovarian cancer: Implications for chemoresistance. Cancer Res., 2002;62:924-931
39. Liu X., Kim C. N., Yang J., Jemmerson R., Wang X.: Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell, 1996;86:147-157
40. Mace P. D., Riedl S. J.: Molecular cell death platforms and assemblies. Curr. Opin. Cell Biol. 2010;22:828-836
41. Malet G., Martin A. G., Orzaez M., Vicent M. J., Masip I., Sanclimens G., Ferrer-Montiel A., Mingarro I., Messeguer A., Fearnhead H. O., Perez-Paya E.: Small molecule inhibitors of Apaf-1-related caspase-3/-9 activation that control mitochondrial-dependent apoptosis. Cell Death Differ., 2006;13:1523-1532
42. Malladi S., Challa-Malladi M., Fearnhead H. O., Bratton S. B.: The Apaf-1•procaspase-9 apoptosome complex functions as a proteolytic-based molecular timer. EMBO J., 2009;28:1916-1925
43. Mashima T., Oh-hara T., Sato S., Mochizuki M., Sugimoto Y., Yamazaki K., Hamada J., Tada M., Moriuchi T., Ishikawa Y., Kato Y., Tomoda H., Yamori T., Tsuruo T.: p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target. J. Natl. Cancer Inst., 2005;97:765-777
44. Nguyen J. T., Wells J. A.: Direct activation of the apoptosis machinery as a mechanism to target cancer cells. Proc. Natl. Acad. Sci. USA, 2002;100:7533-7538
45. Park S. E., Kim N. D., Yoo Y. H.: Acetylcholinesterase plays a pivotal role in apoptosome formation. Cancer Res., 2004;64:2652-2655
46. Pathan N., Marusawa H., Krajewska M., Matsuzawa S., Kim H., Okada K., Torii S., Kitada S., Krajewski S., Welsh K., Pio F., Godzik A., Reed J. C.: TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer. J. Biol. Chem., 2001;276:32220-32229
47. Qi S., Pang Y., Hu Q., Liu Q., Li H., Zhou Y., He T., Liang Q., Liu Y., Yuan X., Luo G., Li H., Wang J., Yan N., Shi Y.: Crystal structure of the Caenorhabditis elegans apoptosome reveals an octameric assembly of CED-4. Cell, 2010;141:446-457
48. Riedl S. J., Li W., Chao Y., Schwarzenbacher R., Shi Y.: Structure of the apoptotic protease activating factor 1 bound to ADP. Nature, 2005;434:926-933
49. Riedl S. J., Salvesen G. S.: The apoptosome: signalling platform of cell death. Nat. Rev. Mol. Cell Biol., 2007;8:405-413
50. Riedl S. J., Shi Y.: Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol., 2004;5:897-907
51. Rodriguez J., Lazebnik Y.: Caspase-9 and Apaf-1 form an active holoenzyme. Genes Dev., 1999;13:3179-3184
52. Sakai T., Liu L., Teng X., Mukai-Sakai R., Shimada H., Kaji R., Mitani T., Matsumoto M., Toida K., Ishimura K., Shishido Y., Mak T. W., Fukui K.: Nucling recruits Apaf-1/pro-caspase-9 complex for the induction of stress-induced apoptosis. J. Biol. Chem., 2004;279:41131-41140
53. Salvesen G. S., Dixit V. M.: Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA, 1999;96:10964-10967
54. Schafer Z. T., Kornbluth S.: The apoptosome: physiological, developmental, and pathological modes of regulation. Dev. Cell, 2006;10:549-561
55. Schafer Z. T., Parrish A. B., Wright K. M., Margolis S. S., Marks J. R., Deshmukh M., Kornbluth S.: Enhanced sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in breast cancer cells. Cancer Res., 2006;66:2210-2218
56. Schimmer A. D., Dalili S., Batey R. A., Riedl S. J.: Targeting XIAP for the treatment of malignancy. Cell Death Differ., 2006;13:179-188
57. Semenkova L., Dudich E., Dudich I., Tokhtamisheva N., Tatulov E., Okruzhnov Y., Garcia-Foncillas J., Palop-Cubillo J. A., Korpela T.: Alpha-fetoprotein positively regulates cytochrome c-mediated caspase activation and apoptosome complex formation. Eur. J. Biochem., 2003;270:4388-4399
58. Shi Y.: Caspase activation: revisiting the induced proximity model. Cell, 2004;117:855-858
59. Shi Y.: Mechanical aspects of apoptosome assembly. Curr. Opin. Cell Biol. 2006;18:677-684
60. Soengas M. S., Capodieci P., Polsky D., Mora J., Esteller M., Opitz-Araya X., McCombie R., Herman J. G., Gerald W. L., Lazebnik Y. A., Cordón-Cardó C., Lowe S. W.: Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature, 2001;409:207-211
61. Sturm I., Bosanquet A. G., Radetzki S., Hummel M., Dorken B., Daniel P. T.: Silencing of APAF-1 in B-CLL results in poor prognosis in the case of concomitant p53 mutation. Int. J. Cancer, 2006;118:2329-2336
62. Takatani T., Takahashi K., Uozumi Y., Shikata E., Yamamoto Y., Ito T., Matsuda T., Schaffer S. W., Fujio Y., Azuma J.: Taurine inhibits apoptosis by preventing formation of the Apaf1/caspase-9 apoptosome. Am. J. Physiol. Cell Physiol., 2004;287:949-953
63. Taylor R. C., Cullen S. P., Martin S. J.: Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol., 2008;9:231-241
64. Teng X., Hardwick J. M.: The apoptosome at high resolution. Cell, 2010;141:402-404
65. Twiddy D., Brown D. G., Adrain C., Jukes R., Martin S. J., Cohen G. M., MacFarlane M., Cain K.: Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex. J. Biol. Chem., 2004;279:19665-19682
66. Verhagen A. M., Ekert P. G., Pakusch M., Silke J., Connolly L. M., Reid G. E.: Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 2000;102:43-53
67. Wang S., Yan-Neale Y., Cai R., Alimov I., Cohen D.: Activation of mitochondrial pathway is crucial for tumor selective induction of apoptosis by LAQ824. Cell Cycle, 2006;5:1662-1668
68. Wolf B. B., Schuler M., Li W., Eggers-Sedlet B., Lee W., Tailor P., Fitzgerald P., Mills G. B., Green D. R.: Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity. J. Biol. Chem., 2001;276:34244-34251
69. Wu G., Chai J., Suber T. L., Wu J. W., Du C., Wang X., Shi Y.: Structural basis of IAP recognition by Smac/DIABLO. Nature, 2000;408:1008-1012
70. Würstle M. L., Laussmann M. A., Rehm M.: The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome. Exp. Cell Res., 2012;318:1213-1220
71. Yamamoto M., Torigoe T., Kamiguchi Y., Nakanishi K., Nabeta C., Asanuma H., Tsuruma T., Sato T., Hata F., Ohmura T., Yamaguchi K., Kurotaki T., Hirata K., Sato N.: A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8 and caspase-9 mediated apoptosis. Cancer Res., 2005;65:8706-8714
72. Yan N., Chai J., Lee E. S., Gu L., Liu Q., He J., Wu J. W., Kokel D., Li H., Hao Q., Xue D., Shi Y.: Structure of the CED-4-CED-9 complex provides insights into programmed cell death in Caenorhabditis elegans. Nature, 2005;437:831-837
73. Yan N., Gu L., Kokel D., Chai J., Li W., Han A., Chen L., Xue D., Shi Y.: Structural, biochemical, and functional analyses of CED-9 recognition by the proapoptotic proteins EGL-1 and CED-4. Mol. Cell, 2004;15:999-1006
74. Yan N., Xu Y., Shi Y.: 2:1 Stoichiometry of the CED-4-CED-9 complex and the tetrameric CED-4: insights into the regulation of CED-3 activation. Cell Cycle, 2006;5:31-34
75. Yang X., Chang H. Y., Baltimore D.: Essential role of CED-4 oligomerization in CED-3 activation and apoptosis. Science, 1998;281:1355-1357
76. Yin Q., Park H., Chung J. Y., Lin S., Lo Y., Da Graca L. S., Jiang X., Wu H.: Caspase-9 holoenzyme is a specific and optimal pro-caspase-3 processing machine. Mol. Cell, 2006;22:259-268
77. Yu X., Acehan D., Ménétret J. F., Booth C. R., Ludtke S. J., Riedl S. J., Shi Y., Wang X., Akey C. W.: A structure of the human apoptosome at 12. 8 A resolution provides insights into this cell death platform. Structure, 2005;13:1725-1735
78. Yu X., Wang L., Acehan D., Wang X., Akey C. W.: Tree-dimensional structure of a double apoptosome formed by the Drosophila Apaf-1-related killer. J. Mol. Biol., 2006;355:577-589
79. Yuan S., Yu X., Topf M., Dorstyn L., Kumar S., Ludtke S. J., Akey C. W.: Structure of the Drosophila apoptosome at 6. 9 A resolution. Structure, 2011;19:128-140
80. Yuan S., Yu X., Topf M., Ludtke S. J., Wang X., Akey C. W.: Structure of an apoptosome procaspase-9 CARD complex. Structure, 2010;18:571-583
81. Zech B., Kohl R., Von Knethen A., Brune B.: Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases. Biochem. J., 2003;371:1055-1064
82. Zlobec I., Minoo P., Baker K., Haegert D., Khetani K., Tornillo L., Terracciano L., Jass J. R. Lugli A.: Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer. Eur. J. Cancer, 2007;43:1101-1107